6-49.9%) reported condom use at last anal sex with a male partner. Temporal trends were not observed in any dataset (p &gt; 0.1). Condom use varied significantly by age in YRBS-National (p &lt; 0.0001) and YRBS-Trends (p = 0.032) with 13-15-year-olds reporting the lowest use in both; age differences were not significant in AMIS (p = 0.919). Our hypothetical intervention averted a mean of 9.0% (95% simulation interval = -5.4%-21.2%) of infections among ASMM.
 
  Condom use among ASMM is low and appears to have remained stable during 2011-2017. Modeling suggests that condom use increases consistent with previous interventions have potential to avert 1 in 11 new HIV infections among ASMM.
 Condom use among ASMM is low and appears to have remained stable during 2011-2017. Modeling suggests that condom use increases consistent with previous interventions have potential to avert 1 in 11 new HIV infections among ASMM.
  Treating chlamydia and gonorrhea in pregnancy has been shown to decrease the associated risk of preterm birth in some studies. Delayed treatment of these infections among non-pregnant patients carries known consequences. It is unclear whether delayed treatment in pregnancy similarly increases adverse outcomes.
 
  We conducted a retrospective cohort study of women who delivered at a safety-net hospital from July 2016 to June 2018.  https://www.selleckchem.com/products/grl0617.html  Women with at least one visit who were tested for chlamydia and gonorrhea were included. Women diagnosed after 36 weeks (preterm analysis) or 31 weeks (early preterm analysis) were excluded. We used multivariable logistic regression to examine the association between no infection, timely treatment (&lt;1 week), and delayed treatment (&gt;1 week, not treated) with preterm (&lt;37 weeks) and early preterm (&lt;32 weeks) birth.
 
  Among 3,154 deliveries, 389 (12%) were preterm. Among 3,107 deliveries, 74 (2%) were early preterm. In adjusted models, women with timely (aOR 1.7, 95% CI 1.0-2.7) and delayed (aOR 1.7, 95% CI 1.1-2.5) treatment had increased odds of preterm birth. Similarly, women with timely (aOR 2.5, 95% CI 1.0-6.2) and delayed (aOR 2.4, 95% CI 1.2-4.9) treatment had increased odds of early preterm birth. Among women who tested positive, multiple infections was not associated with an increase in preterm birth (preterm 17% vs. 20%, p = 0.53; early preterm 5% vs. 6%, p = 0.74).
 
  Chlamydia and gonorrhea are associated with preterm and early preterm birth, regardless of time to treatment. Creative solutions are needed to improve prevention of these infections in pregnancy.
 Chlamydia and gonorrhea are associated with preterm and early preterm birth, regardless of time to treatment. Creative solutions are needed to improve prevention of these infections in pregnancy.
  Since 2010, reported chlamydia and gonorrhea rates decreased among Black women aged 15-19 years and were stable for Black women 20-24 in the United States. Rates increased for older Black women 25-39 and all White women. The BlackWhite rate ratio decreased across age groups. We examined whether trends in reported rates reflected changing prevalence or changing screening. We analyzed trends in reported chlamydia and gonorrhea rates during 2010 to 2018 among women in the United States aged 15-39 years by age and race/ethnicity subgroup, state, and reporting source. Most jurisdictions reported decreased chlamydia and gonorrhea rates among Black teens and increased rates among White teens and older women. Between 2010 and 2018, public clinics reported fewer cases, especially among young Black women, that were not restored by increases elsewhere. We reviewed literature on trends in screening, prevalence, and sequelae. Family planning clinics annual reports showed chlamydia tests among women &lt;25 decreased by 5c clinics likely missed diagnoses among young Black women, a group traditionally at highest risk, and in need of more testing. Innovative approaches to screening are needed.
  Reactive syphilis serologies are investigated by health departments to determine if they represent new infection, reinfection, or treatment failure. Serologies prioritized for investigation based on nontreponemal test titer and age (using a 'reactor grid') undergo manual record search and review. We developed a computerized algorithm that automates the record search and review.
 
  We developed and tested the algorithm using a Florida Department of Health dataset containing serologies reported January 2016-December 2018 and previous records linked to each individual. The algorithm was based on the syphilis case definition, which requires (except primary cases with signs and symptoms) 1) a positive treponemal test and a newly positive nontreponemal test or, 2) a 4-fold increase in nontreponemal test titer. Two additional steps were added to avoid missing cases. New York City Department of Health and Mental Hygiene validated this algorithm.
 
  The algorithm closed more investigations (49.9%) than the reactor grid (27.0%). The algorithm opened 99.4% of the individuals investigated and labeled as cases by the health department; it missed 75 cases. Many investigations opened by the algorithm were closed by the 'reactor grid'; we could not assess how many would have been cases. In New York City, the algorithm closed 70.9% of investigations, likely because more individuals had previous test in the database (88.2%) compared to Florida (56.5%).
 
  The automated algorithm successfully searched and reviewed records to help identify cases of syphilis. We estimate the algorithm would have saved Florida 590 workdays over 3 years.
 The automated algorithm successfully searched and reviewed records to help identify cases of syphilis. We estimate the algorithm would have saved Florida 590 workdays over 3 years.
  Dementia is often underdiagnosed and this problem is more common among some ethnoracial groups.
 
  The objective of this study was to examine racial and ethnic disparities in the timeliness of receiving a clinical diagnosis of dementia.
 
  This was a prospective cohort study.
 
  A total of 3966 participants age 70 years and above with probable dementia in the Health and Retirement Study, linked with their Medicare and Medicaid claims.
 
  We performed logistic regression to compare the likelihood of having a missed or delayed dementia diagnosis in claims by race/ethnicity. We analyzed dementia severity, measured by cognition and daily function, at the time of a dementia diagnosis documented in claims, and estimated average dementia diagnosis delay, by race/ethnicity.
 
  A higher proportion of non-Hispanic Blacks and Hispanics had a missed/delayed clinical dementia diagnosis compared with non-Hispanic Whites (46% and 54% vs. 41%, P&lt;0.001). Fully adjusted logistic regression results suggested more frequent missed/delayed dementia diagnoses among non-Hispanic Blacks (odds ratio=1.